Global Wound Debridement Devices Market is expected to grow with the CAGR of 5.10% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Global wound debridement devices market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in global wound debridement devices market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced wound debridement device product portfolio. For instance, in May 2017, Smith+ Nephew, a global medical technology company, opened its advanced research & development center at Hessel road site in Hull. This center is one of the most equipped medical device R&D centers in Europe. This initiative by both the companies would result in product expansion of the wound debridement devices products, more revenue and would boost the growth in the market.
Smith+Nephew is dominating player in global wound debridement devices market. The other key players existing in the market includes Integra LifeSciences Corporation, Zimmer Biomet, Mölnlycke Health Care AB, Medtronic, Organogenesis Inc, B. Braun Melsungen AG, Coloplast Group,Arobella Medical, Hollister Incorporated, Advanced Medical Solutions Group Plc, , Advanced Medical Solutions Group Plc, BioMonde, BSN medical, DeRoyal Industries, Inc, Itallia Medica SRL, Lohmanna and Rauscher, Misonix, Olympus Corporation, Söring GmbH among others.
Smith+ Nephew has it base headquarters in London, U.K. The company is focused on providing products in orthopaedic reconstruction and trauma, advanced wound management and sports medicine. The company deals in business segments such as Orthopaedic, Sports Medicine and ENT, Advanced Wound Management out of which Advanced Wound Management is the market focused market focused segment.
The company has presence in Africa, Asia, Australia, Europe, Middle East, and America. The company has subsidiaries which are TENET Medical Engineering Inc., (Canada), Smith& Nephew Medical Shanghai Co Ltd (China), Smith & Nephew Healthcare Private Limited (India).
INTEGRA LIFESCIENCES is headquartered in New Jersey, U.S. and was founded in 1989. The company offers innovative solutions in neurosurgery, orthopaedics, reconstructive and general surgery. The company has product category such as Codman Specialty Surgical, Orthopaedics and Tissue Technologies out of which Orthopaedics and Tissue Technology are the market focused category.
The company has wide global presence across North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company has various subsidiaries Miltex Inc (U.S.), Derma Sciences Inc (U.S.), IsoTis Biologics Inc. (U.S.), Tel Biosciences Inc. (U.S.) among others.
Zimmer Biomet is headquartered in Indiana U.S., was founded in year 1927. The company is engaged in designing, manufacturing and marketing of sports medicine, orthopaedic, trauma products, office based technologies, dental implants and related surgical products. The company offers wide range of product in various categories such as Knees, Hips, S.E.T Dental in dental implants, Spine and CMF and Others. out of which others is market focused category.
The company has wide global presence across the world in Europe, Asia Pacific and America. The subsidiaries are Medtech SA(U.S.), Zimmer Knee Creations Inc (U.S.), Zimmer Germany GmbH (Germany).
North America Wound Debridement Devices Market – Industry Trends and Forecast to 2028
Europe Wound Debridement Devices Market – Industry Trends and Forecast to 2028
Asia-Pacific Wound Debridement Devices Market – Industry Trends and Forecast to 2028
Middle East and Africa Wound Debridement Devices Market – Industry Trends and Forecast to 2028
Global Wound Debridement Devices Market – Industry Trends and Forecast to 2028